Philips acquires BioTelemetry for $2.5 billion
… Philips Expands Its Remote Patient Care Monitoring Business WIth BioTelemetry Acquisition …


Philips expedites business strategy to advance in remote patient monitoring

John G. Baresky

BioTelemetry is a renowned innovator in remote patient monitoring and medical device manufacturing

Founded in 1994 and based in Malvern, Pennsylvania, BioTelemetry is a medical technology leader that develops and supports an array of advanced products and programs in these and other patient care segments:

  • Cardiac monitoring
  • Centralized medical imaging
  • Cloud computing and artificial intelligence (AI) driven patient medical data analytics and reporting
  • Original equipment manufacturing (OEM) for healthcare and research organizations

The strategy behind the Philips and BioTelemetry deal

The acquisition of BioTelemetry enables Philips to offer a wider array of products and services to its existing clients with telehealth and remote patient monitoring needs as well as new ones. It also provides a crossover whereas Philips can share various technologies and other resources between its existing healthcare products and telemetry to enrich each of their offerings. Philips will capitalize on these cross-pollination opportunities to strengthen its worldwide competitive position.

Philips is a global medical equipment and technology leader

Founded in 1891 Philips generated about $24 billion in sales during 2019. Its U.S.-based operations are located in Cambridge, Massachusetts and its global headquarters in Amsterdam, The Netherlands. Philips is a well-respected worldwide healthcare leader in:

  • Healthcare informatics
  • Image-guided therapy
  • Patient monitoring
  • Radiology
  • Respiratory
  • Telehealth
  • Cloud-based voice technology
  • Commercial and household lighting
  • Consumer and professional dental care products
  • Engineering and technical product development services

Authentic, fact-based healthcare content marketing writing for medical, business, academic, patient and consumer audiences